FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
![FDA Panel Rejects Use of MDMA for Treatment of PTSD](https://static01.nyt.com/images/2022/05/31/science/04FDA-MDMA/04FDA-MDMA-mediumSquareAt3X.jpg?#)
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 211
usnews Jul 4, 2024 0 208
usnews Jul 4, 2024 0 207
usnews Jul 4, 2024 0 206
usnews Jul 4, 2024 0 205